Biotech Funding Trends and the Rise of Digital Twinning with CEO Scott Ogle

Episode 23

0:00-29:40

EP-23. In the second half of this compelling conversation on BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe continue their deep dive with Scott Ogle, CEO of TruLab. They explore the surprising parallels between the banking and pharma industries, the game-changing role of digital twinning in clinical trials, and the biotech funding landscape. Scott also shares his thoughts on leadership, mentorship, and the impact of the Inflation Reduction Act on pharma innovation. This episode offers listeners valuable insights into the future of drug development and the challenges of balancing professional and personal life in a fast-paced industry. Chapters 1:09 - Comparison of the Banking Industry to the Pharma Industry 5:18 - Data Integrity, Same For Decentralized Trials? 8:33 - Biotech Funding Trends 11:18 - NEW NEWS! – Digital Twinning in Clinical Trials 16:15 - What Advice Would You Give to Your Younger Self? 20:57 - Mentorship and Its Impact, How it Shaped Scott 23:45 - Balancing Work and Personal Life 24:32 - The Inflation Reduction Act and Innovation Takeaways The regulatory environment in pharma can slow down innovation. Digital twinning in clinical trials could revolutionize drug development. Family influences play a significant role in shaping business perspectives. The need for a strong company culture to maintain values during growth. Biotech funding trends are influenced by macroeconomic factors like interest rates.

Publisher

BioTalk Unzipped

Link

biotalk-unzipped.captivate.fm/episode/biotech-funding-trends-and-the-rise-of-digital-twinning-with-ceo-scott-ogle

Published

October 21, 2024

Duration

30 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Gregory Austin

BU

BioTalk Unzipped

@biotalkunzipped

#biotechfundingtrends #digitaltwinning #ceoscottogle #lifesciences #medicine

The Nile